Skip to main content

Ventricular Tachycardia Ablation

  • Chapter
  • First Online:
Decoding Cardiac Electrophysiology

Abstract

Ventricular tachycardia (VT) ablation can in many cases be one of the most challenging areas of invasive electrophysiology. Reducing symptoms associated with VT and reducing the morbidity associated with ICD shocks remain the most common indications for VT ablation . There are three broad categories of VT: VT secondary to ischaemic heart disease, non-ischaemic heart disease, and normal heart VT. The approaches to ablation in each setting are slightly different and are outlined here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nanthakumar K, Epstein AE, Kay GN, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. J Am Coll Cardiol. 2004;44:2166–72.

    Article  Google Scholar 

  2. Connolly SJ, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA. 2006;295:165–71.

    Article  CAS  Google Scholar 

  3. Al-Khatib SM, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15:e73–189.

    Article  Google Scholar 

  4. Sapp JL, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111–21.

    Article  CAS  Google Scholar 

  5. Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-resolution mapping of postinfarction reentrant ventricular tachycardia: electrophysiological characterization of the circuit. Circulation. 2016;134:314–27.

    Article  Google Scholar 

  6. Stevenson WG, Soejima K. Catheter ablation for ventricular tachycardia. Circulation. 2007;115:2750–60.

    Article  Google Scholar 

  7. Stevenson WG, et al. Exploring postinfarction reentrant ventricular tachycardia with entrainment mapping. J Am Coll Cardiol. 1997;29:1180–9.

    Article  CAS  Google Scholar 

  8. Stevenson WG, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation. 1993;88:1647–70.

    Article  CAS  Google Scholar 

  9. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101:1288–96.

    Article  CAS  Google Scholar 

  10. Arenal A, et al. Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease. J Am Coll Cardiol. 2003;41:81–92.

    Article  Google Scholar 

  11. Vergara P, et al. Late potentials abolition as an additional technique for reduction of arrhythmia recurrence in scar related ventricular tachycardia ablation. J Cardiovasc Electrophysiol. 2012;23:621–7.

    Article  Google Scholar 

  12. Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13:569–83.

    Article  Google Scholar 

  13. Jaïs P, et al. Elimination of local abnormal ventricular activities: a new end point for substrate modification in patients with scar-related ventricular tachycardia. Circulation. 2012;125:2184–96.

    Article  Google Scholar 

  14. Di Biase L, et al. Ablation of clinical stable ventricular tachycardia versus substrate based ablation on long term freedom from any VT: results from a randomized multicenter study vista. Heart Rhythm. 2014.

    Google Scholar 

  15. Biase LD, et al. Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:132–41.

    Article  Google Scholar 

  16. Arenal A, et al. Tachycardia-related channel in the scar tissue in patients with sustained monomorphic ventricular tachycardias: influence of the voltage scar definition. Circulation. 2004;110:2568–74.

    Article  Google Scholar 

  17. de Chillou C, et al. Localizing the critical isthmus of postinfarct ventricular tachycardia: the value of pace-mapping during sinus rhythm. Heart Rhythm. 2014;11:175–81.

    Article  Google Scholar 

  18. Szumowski L, et al. Mapping and ablation of polymorphic ventricular tachycardia after myocardial infarction. J Am Coll Cardiol. 2004;44:1700–6.

    Article  Google Scholar 

  19. Sosa E, Scanavacca M. Percutaneous pericardial access for mapping and ablation of epicardial ventricular tachycardias. Circulation. 2007. https://doi.org/10.1161/circulationaha.107.701623.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neil T. Srinivasan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Srinivasan, N.T., Cambridge, A. (2020). Ventricular Tachycardia Ablation. In: Sohaib, A. (eds) Decoding Cardiac Electrophysiology. Springer, Cham. https://doi.org/10.1007/978-3-030-28672-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28672-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28671-2

  • Online ISBN: 978-3-030-28672-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics